gland pharma glp-1 manufacturing capacity 10mg Vial (Semaglutide) | Research Peptide India's GLP-1 Market Heats Up

Poor pregnancy outcome for women with Type 2 diabetes

in Heath Science, Touro University B.S in Biology, Florida International University Obesity Medical Association Member NCCPA Certification Learn More Sophia Ro Clinical Operations Manager 10+ years in patient care M.S

Clinical evidence (based on the literature) on GLP-1 RAs licensed in South Asia or under regulatory approval in one or more South Asian countries is presented and based on prescription pattern and the geography of the reported patient group

Other supplements should be approached cautiously, especially when evidence is inconsistent or safety concerns exist

doi: 10.21037/jtd-cus-2020-012 35